Jazz Pharmaceuticals (JAZZ) Q4 Earnings Lag Estimates

Jazz Pharmaceuticals (JAZZ) came out with quarterly earnings of $5.02 per share, missing the Zacks Consensus Estimate of$ 5.26 per share. This compares to loss of $0.07 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -4.56%. A quarter ago, it was expected that this drugmaker would post earnings of$ 4.90 per share when it actually produced earnings of $4.84, delivering a surprise of -1.22%.Over the last four quarters, the compa ...